Last reviewed · How we verify
WRSS1
At a glance
| Generic name | WRSS1 |
|---|---|
| Sponsor | PATH |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Shigella WRSS1 Vaccine Trial in Bangladesh (PHASE1)
- Safety Study of Live Attenuated Oral Shigella (WRSS1) Vaccine in Bangladeshi Adults and Children (NA)
- Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- WRSS1 CI brief — competitive landscape report
- WRSS1 updates RSS · CI watch RSS
- PATH portfolio CI